drugset / Trial / NCT02981212
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
Phase 4
Unknown
100 enrolled
Yonsei University
Chonbuk National University Hospital · collabChong Kun Dang Pharmaceutical · collabInje University · collabKyung Hee University Hospital at Gangdong · collabKyungpook National University Hospital · collabPusan National University Yangsan Hospital · collabSeoul St. Mary's Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this clinical study is to evaluate the efficacy and safety of that test group was administered with Mycophenolate Mofetil in combination with corticosteroid in patients with advanced IgA nephropathy. The control group will be observed for up to 48 weeks without administration of Mycophenolate Mofetil.
Timeline
- Start
- 2016-06
- Primary completion
- 2018-08
- Completion
- 2018-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mycophenolate Mofetil | Small molecule | 1500 mg | Oral |
| Subject | Mycophenolate Mofetil | Small molecule | 2000 mg | Oral |
| Background | Dexamethasone | Small molecule | — | — |
| Background | Prednisolone | Other / unclassified | — | — |